LYVE-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of LYVE-1 monoclonal antibodies for research in lymphatic biology and related fields. LYVE-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LYVE-1, or Lymphatic Vessel Endothelial Hyaluronan Receptor 1, plays a crucial role in lymphatic vessel formation and function, as well as in the transport of hyaluronan, a key component of the extracellular matrix. LYVE-1 expression is vital for maintaining tissue homeostasis and regulating immune responses, making it an important marker for studying lymphatic endothelial cells. Understanding LYVE-1 function provides insights into various diseases, including cancer and inflammation. Researchers can investigate lymphatic vessel development using specific LYVE-1 monoclonal antibodies. LYVE-1 research advances our knowledge of lymphatic system disorders and potential therapeutic approaches. LYVE-1 monoclonal antibodies enable detailed analysis of lymphatic endothelial cell behavior and migration patterns. Santa Cruz Biotechnology monoclonal antibodies for LYVE-1 support researchers worldwide in advancing our understanding of lymphatic biology and disease mechanisms.